Staphylococcus aureus is a major cause of human disease, responsible for half a million infections and approximately 20,000 deaths per year in the United States alone 1, 2 . This pathogen secretes a-hemolysin, a pore-forming cytotoxin that contributes to the pathogenesis of pneumonia [3] [4] [5] . a-hemolysin injures epithelial cells in vitro by interacting with its receptor, the zinc-dependent metalloprotease ADAM10 (ref. 6) . We show here that mice harboring a conditional disruption of the Adam10 gene in lung epithelium are resistant to lethal pneumonia. Investigation of the molecular mechanism of toxin-receptor function revealed that a-hemolysin upregulates ADAM10 metalloprotease activity in alveolar epithelial cells, resulting in cleavage of the adherens junction protein E-cadherin. Cleavage is associated with disruption of epithelial barrier function, contributing to the pathogenesis of lethal acute lung injury. A metalloprotease inhibitor of ADAM10 prevents E-cadherin cleavage in response to Hla; similarly, toxin-dependent E-cadherin proteolysis and barrier disruption is attenuated in ADAM10-knockout mice. Together, these data attest to the function of ADAM10 as the cellular receptor for a-hemolysin. The observation that a-hemolysin can usurp the metalloprotease activity of its receptor reveals a previously unknown mechanism of pore-forming cytotoxin action in which pathologic insults are not solely the result of irreversible membrane injury and defines ADAM10 inhibition as a strategy to attenuate a-hemolysin-induced disease.
Pore-forming cytotoxins (PFTs) are a family of bacterial virulence factors that cause eukaryotic cell injury and death 7 . Staphylococcus aureus encodes multiple PFTs, the best-studied being α-hemolysin (Hla), which is expressed by almost all strains 8 . Hla is essential for S. aureus-dependent diseases involving epithelial cell-lined interfaces, including pneumonia, dermonecrotic skin infection, corneal infection and toxic shock syndrome 3, 4, [9] [10] [11] . Hla induces injury by forming a lipidbilayer-penetrating heptameric pore 12 . The identification of ADAM10 as the Hla receptor provides an opportunity to elucidate receptor function in disease and define mechanisms of toxin-induced injury.
ADAM10-knockout mice show early embryonic lethality 13 . To examine the requirement for ADAM10 in staphylococcal pneumonia, we used surfactant protein C (SP-C) promoter-driven expression of Cre recombinase to generate mice harboring an Adam10 deletion in respiratory epithelium ( Supplementary Fig. 1a ) 14, 15 . This system achieves recombination in SP-C-expressing progenitor type II pneumocytes, yielding ADAM10-deficient type I pneumocytes that constitute the alveolar epithelium; genomic analysis and protein expression confirmed the recombination (Supplementary Fig. 1b,c) . Knockout mice (Adam10 −/− mice) were resistant to lethal pneumonia caused by methicillin-sensitive ( Fig. 1a ) and methicillin-resistant ( Supplementary  Fig. 1d ) S. aureus. Histopathological examination of Adam10 −/− lungs after sublethal infection revealed limited inflammatory cell influx and preservation of alveolar structure (Fig. 1b) . Lethal infection in ADAM10-expressing littermate control mice caused widespread loss of aerated lung characterized by tissue solidification and cellular infiltration, whereas Adam10 −/− mice showed greater preservation of viable lung tissue with reduced infiltration of immune cells ( Fig. 1c) . ADAM10 knockout did not alter lung bacterial load ( Supplementary  Fig. 1e ), in contrast to the reduction observed in mice infected with Hla-deficient S. aureus or upon toxin neutralization 5, 16 . ADAM10 expression is thus essential for progressive lethal disease, however it does not affect toxin-mediated control of the tissue bacterial load.
Zinc-dependent catalysis by ADAM10 results in ectodomain cleavage of proteins that modulate immunity and of E-cadherin, which facilitates interepithelial cell adhesion 17, 18 . As epithelial barrier integrity is disrupted in pneumonia, we hypothesized that ADAM10 enzymatic activity may contribute to toxin-mediated injury. To assess whether Hla alters ADAM10 metalloprotease activity, we performed a fluorogenic peptide cleavage assay on A549 alveolar epithelial cells treated with 10 µg ml −1 active Hla (300 nM), a subcytolytic concentration ( Supplementary Fig. 2a ). Hla treatment led to increased metalloprotease activity in cells transfected with an irrelevant siRNA ( Fig. 2a) , a response that was not elicited by a non-oligomerizing Hla H35L mutant 19 . ADAM10-specific siRNA-treated cells showed activity comparable to irrelevant siRNA-transfected cells only at the 30-min time point after toxin addition, probably owing to residual ADAM10 expression ( Fig. 2a, Supplementary Fig. 2b and ref. 6); activity in ADAM10specific siRNA-treated cells thereafter was markedly reduced.
To evaluate the effects of increased ADAM10 activity on barrier function, we used electrical cell substrate impedance sensing (ECIS) to record toxin-induced changes in A549 monolayer resistance. Hla caused rapid loss of resistance in irrelevant siRNA transfectants, whereas ADAM10 knockdown preserved barrier function similar to controls (PBS-treated and Hla H35L -infected cells) (Fig. 2b) . The requirement for ADAM10 in barrier disruption was evident even at 50 µg ml −1 Hla, a concentration at which cytolytic injury occurs shortly after intoxication and can be receptor independent ( Supplementary Fig. 2a and ref. 6) .
Bacteria circumvent host barrier defenses through virulence factors that dismantle the structural framework of the epithelium 20 . Proteolysis of the E-cadherin extracellular domain by ADAM10 severs the homotypic, adherens junction-based linkage between adjacent cells 21 . To examine whether Hla-induced ADAM10 activation causes E-cadherin cleavage, we analyzed lysates from A549 cells by immunoprecipitation and immunoblotting. ADAM10-mediated cleavage releases the E-cadherin N-terminal extracellular domain, leading to a reduction in full-length protein and appearance of an intracellular C-terminal fragment (CTF) 21 . Ionomycin induces ADAM10 activity 22 , enhancing cleavage compared to DMSO or Hla H35L treatment, whereas Hla (20 µg ml −1 ) triggered rapid cleavage ( Fig. 2c) . Concentrations of Hla as low as 1 µg ml −1 induced cleavage within 1 h ( Fig. 2d) . Immunofluorescence microscopy confirmed loss of E-cadherin ( Fig. 2e ). Cells transfected with ADAM10-specific siRNA did not show toxin-induced CTF generation ( Supplementary Fig. 2c ), maintaining full-length E-cadherin expression ( Supplementary Fig. 2d ).
To define the structural form of Hla that activates ADAM10, we examined E-cadherin cleavage by Hla mutant proteins that mimic toxin assembly intermediates. These include monomeric Hla H35L that binds ADAM10 but cannot form stable heptamers and a pre-pore locked mutant (Hla PPL ) containing an engineered disulfide bond that allows heptamer formation but prevents toxin insertion into the membrane until dithiothreitol (DTT) is present. Only Hla PPL in the presence of DTT activated ADAM10 and led to E-cadherin cleavage ( Fig. 2f) , indicating a requirement for the pore. Methyl-β-cyclodextrin-mediated blockade of the pore abrogated metalloprotease activation and E-cadherin cleavage (Fig. 2f) . Calcium in the medium, as observed with cells grown in F12K, Dulbecco's PBS (containing Ca 2+ , Mg 2+ and K + ) and PBS plus Ca 2+ , was required for metalloprotease activation and E-cadherin cleavage (Fig. 2g) . Together, these data suggest that the Hla pore may serve as an ion conduit, or that it may rely on the presence of calcium to facilitate ADAM10 activation. To further examine pore formation in ADAM10 activation, we treated A549 cells with Streptococcus pneumoniae pneumolysin (PLY), a cholesteroldependent PFT implicated in pneumococcal pneumonia 23 . PLY is highly cytotoxic, causing >50% maximal cell lysis at concentrations as low as 0.5 µg ml −1 . We found that cell-associated metalloprotease activity was induced by PLY, most notably at lower toxin concentrations wherein E-cadherin cleavage was also observed (Supplementary Fig. 2e) . These data suggest that ADAM10 may be used by multiple PFTs for pathological E-cadherin cleavage. Cleavage was most prominent at overtly cytotoxic PLY concentrations, probably reflecting metalloproteasedependent E-cadherin cleavage during apoptosis triggered by PLY 24, 25 . The receptor function of ADAM10 may specifically target Hla to the epithelium, potentiating the ability of the small pore to activate ADAM10 and cause E-cadherin cleavage at subcytolytic concentrations.
Acute lung injury is associated with loss of epithelial barrier function, leading to accumulation of cellular, proteinaceous edema 26 . To examine the role of Hla in E-cadherin cleavage and barrier disruption in vivo, we used a mouse S. aureus pneumonia model. Hla-deficient strains show limited virulence in this model, and toxin neutralization protects against disease 5, 16 . We infected C57BL/6J mice with wild-type (WT) S. aureus USA300/LAC or an isogenic Hla-deficient mutant (Hla − ) 3 . We performed bronchoalveolar lavage (BAL) to evaluate E-cadherin cleavage, measuring N-terminal fragment (NTF) release. Infection with nontoxigenic S. aureus led to minimal NTF detection, in contrast to WT infection (Fig. 3a) . We observed alveolar barrier disruption evidenced by an elevated total cell count in BAL fluid after WT infection, a response that was blunted in Hla − infection (Fig. 3b) rising through 24 h (Fig. 3c) . We observed minimal proteinaceous edema in Hla − S. aureus-infected mice at 6 and 24 h, with increased BAL protein content at 12 h probably reflecting the host inflammatory state 3, 5 . Toxin-independent inflammation in this setting may result from other virulence factors, notably Protein A-mediated tumor necrosis factor receptor activation 27 or the effects of CXCR3 chemokines on host immune cells, which were recently described as contributing to excessive pulmonary inflammation in S. aureus infection 28 .
To examine Hla sufficiency in eliciting E-cadherin cleavage, we delivered 0.4 µg Hla or Hla H35L intranasally to mice. Only Hla treatment led to NTF accumulation (Fig. 3d) with increased total cell counts in BAL fluid and alveolar protein abundance (Supplementary Fig. 3a) . Within 4 h, when signs of injury were not yet apparent, E-cadherin cleavage was already evident (Fig. 3e) . Hla induced minimal E-cadherin cleavage in Adam10 −/− mice (Fig. 3f) . BAL cell recovery in Adam10 −/− mice was blunted, with markedly reduced protein accumulation (Fig. 3g) . Infection of C57BL/6J mice with a ~2.5-fold higher inoculum of Hla − S. aureus did not result in increased E-cadherin cleavage (Fig. 3h) , protein leakage ( Fig. 3i) or death (data not shown), in spite of a trend toward increased cell recovery in BAL fluid (Fig. 3i) . Delivery of this high Hla − S. aureus inoculum to Adam10 −/− mice and controls resulted in similar disease severity (Supplementary Fig. 3b) .
These observations raised the possibility that metalloprotease inhibition may mitigate Hla action. Treatment of A549 cells with the ADAM10specific inhibitor GI254023X (ref. 29 ) abrogated toxin-induced E-cadherin cleavage ( Fig. 4a and Supplementary Fig. 4a) , correlating with preservation of monolayer resistance (Fig. 4b) . A549 cells do not form a polarized epithelium, thus we confirmed our observations in the 16HBE14o-bronchial epithelial line (Supplementary Fig. 4b-d ). ADAM10 expression in 16HBE14o-cells did not show polarity ( Supplementary Fig. 4e and ref. 30 ). Unexpectedly, GI254023X impaired Hla binding and oligomerization on A549 cells (Fig. 4c) , perhaps owing to conformational changes induced in ADAM10 upon inhibitor binding that precludes Hla association. GI254023X treatment of mice prevented E-cadherin cleavage (Fig. 4d) , reduced alveolar exudates (Supplementary Fig. 5a ) and protected against lethal pneumonia (Fig. 4e) . The addition of GI254023X-pretreated Hla to rabbit red blood cells did not alter hemolysis. In contrast, GI254023X pretreatment of rabbit red blood cells blunted hemolysis, confirming that this strategy targets the host (Supplementary Fig. 5b) . GI254023X prevented PLYinduced E-cadherin cleavage (Supplementary Fig. 6) , thus possibly representing a broadly applicable strategy against PFT-mediated injury.
These studies enhance knowledge of PFT biology, defining the role of a proteinaceous receptor in S. aureus pathogenesis. Hla's use of ADAM10 as its receptor confers functionality to the toxin, coupling target binding with epithelial barrier disruption. This mechanism of action permits a clearer understanding of the toxin's tropism for barrier-forming cells, and suggests that toxin-induced barrier disruption may be a crucial early pathological disturbance that is directly linked to lethal disease outcome. Additional studies are necessary to characterize the independent contributions of Hla-induced cytolysis and ADAM10-mediated E-cadherin cleavage to barrier disruption; these may be quantitatively and temporally distinct during infection. Investigation of ADAM10 as a mediator of barrier injury induced by PFTs may reveal a more generalized role for the enzyme in bacterial pathogenesis, highlighting avenues for disease intervention.
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Recombinant proteins, cell lines, antibodies and reagents. Tagged Hla and
Hla H35L fusion proteins were purified, their activity quantified as previously described 31, 32 and used on the basis of their specific activity, as detailed in the Supplementary Methods. The Hla PPL mutant was generated through introduction of cysteine residues at positions 108 and 154. A549 cells were cultured in F12K medium supplemented with 10% FBS and l-glutamine. 16HBE14o-cells were cultured in MEM (CellGro) supplemented with 1% FBS (CellGro) and l-glutamine (Gibco) as previously described 33 . Antibodies were purchased and used as detailed in the Supplementary Methods. The ADAM10 inhibitor GI254023X was synthesized according to a previously published synthetic path 34 by OKeanos Tech, Ltd. The compound was used for in vitro and in vivo studies as detailed in the Supplementary Methods. Methyl-β-cyclodextrin was purchased from Sigma and used at a final concentration of 10 µM.
Bacterial strains and culture. S. aureus strains Newman, USA300 and the Hla-deficient USA300 strain containing a transposon insertion in the hla locus (Hla − ) were described previously 32, 35 , and we propagated them in tryptic soy broth (BD Biosciences). Cell and tissue-based assays. siRNA transfection of cells, flow cytometry and LDH assays was conducted as previously reported 31 . For metalloprotease assays, A549 cells were plated in 96-well tissue culture plates at a density of 1.5 × 10 4 cells per well 24 h before experimentation. Cells were washed once in PBS, and then purified, active Hla or Hla mutants (10 µg ml −1 or as specified), PLY (as specified) or control PBS was added to each well in unsupplemented F12K medium or specific buffers where noted for the time periods indicated in each figure or corresponding legend. Cells were then washed once in 25 mM Tris, pH 8.0 buffer, and incubated for 30 min at 37 °C with 10 µM fluorogenic peptide substrate (Mca-PLAQAV-Dpa-RSSSR-NH 2 , R&D Systems) diluted in 25 mM Tris, pH 8.0. Fluorescence intensity was read on a BioTek Synergy HT plate reader.
Generation of Adam10
For biochemical detection of E-cadherin in A549 cells, 1 × 10 6 cells were plated in 10-cm tissue culture dishes 48-72 h before experimentation. Washed monolayers were incubated with 20 µg ml −1 purified Hla or PLY in F12K medium or other buffers without supplements (Fig. 2g) for the time periods described in each figure or corresponding legend. Ionomycin (5 µM) or DMSO controls were added to monolayers 35 min before cell processing. Cells were lysed and immunoprecipitations and immunoblotting performed as detailed in the Supplementary Methods.
Fluorescence microscopy was performed on A549 or 16HBE14o-cells that were seeded onto coverslips in 24-well plates at a density of 8 × 10 4 cells per well 48-72 h before experimentation. Cells were then treated with 20-50 µg ml −1 active Hla in F12K medium without supplements for 2 h and then fixed, stained and visualized as described in the Supplementary Methods. Image processing and analysis of immunofluorescence microscopy was performed with ImageJ software (US National Institutes of Health).
Tissue specimens for immunohistochemical analysis were fixed in 10% neutral buffered formalin, paraffin embedded, sectioned, subjected to antigen retrieval and stained for 1 h with either ADAM10-specific antibody (5 µg ml −1 , Santa Cruz) or E-cadherin-specific antibody (20 µg ml −1 , Invitrogen). Subsequent processing and visualization were performed as described in the Supplementary Methods.
Epithelial cell impedance sensing studies. We seeded 8 × 10 4 A549 cells in 300 µl complete medium in 8W10E cultureware and incubated them at 37 °C in a CO 2 incubator. Electrical resistance of the cell layer was recorded continuously on an ECIS system (Applied BioPhysics) until a stable resistance of approximately 500-600 ohms was documented, after which the indicated treatments were applied and monitoring resumed.
Mouse S. aureus infection, treatment with active Hla and bronchoalveolar lavage.
Mouse experiments were reviewed, approved and supervised by the Institutional Animal Care and Use Committee at the University of Chicago. Mouse infections were performed by delivering S. aureus via the intranasal route as detailed in the Supplementary Methods. All mice used in these studies weighed between 16 and 19 g to maintain consistency with the S. aureus pneumonia model we have extensively characterized 32, 36 . Purified, active Hla rendered endotoxin free via serial extraction with Triton-114 was delivered to all mice by intranasal inoculation in a total volume of 30 µl. BAL, studies on BAL fluid, and scoring of infected mice are detailed in the Supplementary Methods. Statistical analyses. Statistical significance of BAL fluid studies, intensity quantification for microscopy and clinical disease severity was calculated using the two-tailed Student's t-test. Significance of mouse mortality studies was quantified by log-rank test.
